Epigenomics AG (Epigenomics AG) Operating Cash Flow per Share : $-15.81 (TTM As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Epigenomics AG Operating Cash Flow per Share?

Epigenomics AG's operating cash flow per share for the three months ended in Jun. 2023 was $-4.04. Epigenomics AG's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2023 was $-15.81.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 36.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 32.50% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 20.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Epigenomics AG's Operating Cash Flow per Share or its related term are showing as below:

EPGNF' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -54.6 Med: 15.8 Max: 50.3
Current: 36.3

During the past 13 years, Epigenomics AG's highest 3-Year average Operating Cash Flow per Share Growth Rate was 50.30% per year. The lowest was -54.60% per year. And the median was 15.80% per year.

EPGNF's 3-Year OCF Growth Rate is ranked better than
87.43% of 175 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.1 vs EPGNF: 36.30

Epigenomics AG Operating Cash Flow per Share Historical Data

The historical data trend for Epigenomics AG's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epigenomics AG Operating Cash Flow per Share Chart

Epigenomics AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Operating Cash Flow per Share

Get a 7-Day Free Trial

-68.87

-63.59

-40.29

-8.38

-15.67

Epigenomics AG Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-3.45	-3.01	-4.65	-4.12	-4.04

Competitive Comparison of Epigenomics AG's Operating Cash Flow per Share

For the Diagnostics & Research subindustry, Epigenomics AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Epigenomics AG's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Epigenomics AG's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Epigenomics AG's Price-to-Operating-Cash-Flow falls into.

Epigenomics AG Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Epigenomics AG's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (A: Dec. 2022 )	=	Cash Flow from Operations (A: Dec. 2022 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2022 )
	=	-12.737	/	0.813
	=	-15.67

Epigenomics AG's Operating Cash Flow per Share for the quarter that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (Q: Jun. 2023 )	=	Cash Flow from Operations (Q: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2023 )
	=	-3.442	/	0.853
	=	-4.04

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-15.81

Epigenomics AG Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Epigenomics AG's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Epigenomics AG (Epigenomics AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Epigenomics AG (OTCPK:EPGNF) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

ECX:Germany

Address

Geneststrasse 5, Berlin, BB, DEU, 10829

Website

https://www.epigenomics.com

Epigenomics AG is a molecular diagnostics company, that focuses on developing and commercializing in vitro diagnostic liquid biopsy tests for the screening, early detection, and diagnosis of cancer. The company develops and markets procedures and devices for the production in quantity of particular epigenetic parameters such as DNA methylation patterns as well as the information technology bases necessary for their procurement and evaluation. It is engaged in the development of novel molecular diagnostic products for cancer. The company products include Epi proColon, Epi BiSKit, HCCBloodTest, and Epi proLung. The company operates in Europe, Asia, and North America, majority of its revenue derives from Asia.

Epigenomics AG (Epigenomics AG) Headlines

From GuruFocus

Encode Ideas, L.P. to host Virtual 1x1 Webinar with Epigenomics AG (ECX.DE, EPGNF) on Tuesday, July 28th at 10:30 AM ET

By ACCESSWIRE ACCESSWIRE • 07-23-2020